Clinical Trial of Low Intensity Shockwaves Therapy for Erectile Dysfunction Post-Radical Prostatectomy

Exclusion Criteria

• •1. Be currently participating in a clinical trial or have recently received an investigational therapy within the past 30 days that may interfere with the results of this study.
• •2. Be under judicial protection (prison or custody).
• •3. Be an adult under guardianship.
• •4. Refuse to sign the informed consent.
• •5. Have evidence of venous leak prior to surgery or use of PDE5i prior to surgery
• •6. Have past radiation therapy of the pelvic region or hormonal therapy with androgen deprivation within 12 months prior to enrollment.
• •7. Be recovering from any cancer within 12 months prior to enrollment (other than prostate cancer)
• •8. Have Neurological disease such as Alzheimer's or Parkinson's disease which affects erectile function (at the discretion of the investigator).
• •9. Have a Psychiatric diagnosis or medications such as antidepressants, anxiolytic, antipsychotic that affects erectile function or any other medications (at the discretion of the investigator).
• •10. Have an anatomical malformation of the penis, including Peyronie's disease.
• •11. Have testosterone level \<300 or \>1000 ng/dL within 1 month prior to enrollment.
• •12. Be using blood thinners with international normalized ratio (INR) to be \> 3.
• •13. Have received shockwave therapy for at least 6 months before enrollment.
• •14. Have detectable PSA value after the radical prostatectomy.
• •15. Require radiation therapy after radical prostatectomy.
• •16. Require hormonal therapy after radical prostatectomy.